We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine.
- Authors
Levin, M J; Oxman, M N; Zhang, J H; Johnson, G R; Stanley, H; Hayward, A R; Caulfield, M J; Irwin, M R; Smith, J G; Clair, J; Chan, I S F; Williams, H; Harbecke, R; Marchese, R; Straus, S E; Gershon, A; Weinberg, A; Veterans Affairs Cooperative Studies Program Shingles Prevention Study Investigators
- Abstract
A double-blind, placebo-controlled trial that involved 38,546 subjects > or =60 years old demonstrated efficacy of a high-potency live-attenuated Oka/Merck varicella-zoster virus (VZV) vaccine. The trial included an immunology substudy to determine the relationship of VZV-specific immune responses to vaccination and clinical outcome.
- Publication
The Journal of infectious diseases, 2008, Vol 197, Issue 6, p825
- ISSN
0022-1899
- Publication type
Journal Article
- DOI
10.1086/528696